Lv12
58 积分 2025-02-23 加入
Prognostic and therapeutic implications of measurable residual disease levels during remission induction of childhood ALL
2小时前
待确认
Prognostic and therapeutic implications of measurable residual disease levels during remission induction of childhood ALL
3小时前
已完结
How I individualize treatment for chronic-phase CML
6天前
已关闭
Impact of the addition of rituximab in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia
6天前
已完结
National cancer system metrics and leukemia outcomes: an analysis of global data for pediatric and adult patients
6天前
已完结
Age-related prognoses of genetic subtypes in B-cell acute lymphoblastic leukemia/lymphoma (B-ALL): insights from a decade of national data
6天前
已完结
Advancing chronic myeloid leukemia research with next-generation sequencing: potential benefits, limitations, and future clinical integration
7天前
已完结
National cancer system metrics and leukemia outcomes: an analysis of global data for pediatric and adult patients
7天前
已完结
HSR25-174: Impact of Adverse Events on Quality of Life in Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors – Results From the Survey on Humanistic Burden of Intolerance to First or Second TKIs (SHIFT) Study
9天前
已关闭
HSR25-182: Patient-Physician Communication About Adverse Events and Impact on Quality of Life to Foster Shared Decision-Making in Chronic Myeloid Leukemia
9天前
已关闭
皖公网安备34019202002308
